Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Chronic kidney disease stage progression in liver transplant recipients.

Lamattina JC, Foley DP, Mezrich JD, Fernandez LA, Vidyasagar V, D'Alessandro AM, Musat AI, Samaniego-Picota MD, Pascual J, Alejandro MD, Leverson GE, Pirsch JD, Djamali A.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1851-7. doi: 10.2215/CJN.00650111. Epub 2011 Jul 22.

2.

Chronic kidney disease following liver transplantation: a South Australian experience.

Ramachandran J, Juneja R, John L, Dutta AK, Chen JW, Woodman RJ, Wigg AJ.

Transplant Proc. 2010 Nov;42(9):3644-6. doi: 10.1016/j.transproceed.2010.06.022.

PMID:
21094832
3.

Chronic kidney disease after orthotopic liver transplantation in recipients receiving tacrolimus.

Garces G, Contreras G, Carvalho D, Jaraba IM, Carvalho C, Tzakis A, Moon J, Ratnam K, Roth D.

Clin Nephrol. 2011 Feb;75(2):150-7.

PMID:
21255545
4.

Low estimated glomerular filtration rate and chronic kidney failure following liver transplant: a retrospective cohort study.

Narciso RC, Ferraz LR, Rodrigues CJ, Monte JC, Mie S, Dos Santos OF, Paes ÂT, Cendoroglo M, Jaber BL, Durão MS Jr, Batista MC.

Int J Artif Organs. 2013 Jul;36(7):498-505. doi: 10.5301/ijao.5000201. Epub 2013 May 20.

PMID:
23897230
5.

Prognosis of CKD patients receiving outpatient nephrology care in Italy.

De Nicola L, Chiodini P, Zoccali C, Borrelli S, Cianciaruso B, Di Iorio B, Santoro D, Giancaspro V, Abaterusso C, Gallo C, Conte G, Minutolo R; SIN-TABLE CKD Study Group.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2421-8. doi: 10.2215/CJN.01180211. Epub 2011 Aug 4.

6.

Renal outcomes after liver transplantation in the model for end-stage liver disease era.

Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS.

Liver Transpl. 2009 Sep;15(9):1142-8. doi: 10.1002/lt.21821.

7.

Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.

Obi Y, Kimura T, Nagasawa Y, Yamamoto R, Yasuda K, Sasaki K, Kitamura H, Imai E, Rakugi H, Isaka Y, Hayashi T.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1558-65. doi: 10.2215/CJN.08061109. Epub 2010 Jun 17.

8.

Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.

Khalkhali HR, Ghafari A, Hajizadeh E, Kazemnejad A.

Exp Clin Transplant. 2010 Dec;8(4):277-82.

9.

Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan.

Yamashita T, Yoshida T, Ogawa T, Tsuchiya K, Nitta K.

Clin Exp Nephrol. 2011 Dec;15(6):831-40. doi: 10.1007/s10157-011-0501-6. Epub 2011 Jul 30.

PMID:
21800234
10.

Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up.

LaMattina JC, Mezrich JD, Fernandez LA, D'Alessandro AM, Djamali A, Musat AI, Pirsch JD, Foley DP.

Clin Transplant. 2013 Mar-Apr;27(2):193-202. doi: 10.1111/ctr.12063. Epub 2013 Jan 7.

11.

Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.

Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Rajender Reddy K; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2013 Jun;19(6):619-26. doi: 10.1002/lt.23648.

12.
13.

The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.

Goldberg DS, Ruebner RL, Abt PL.

Am J Transplant. 2015 Oct;15(10):2732-8. doi: 10.1111/ajt.13314. Epub 2015 May 12.

14.

Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.

Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID.

Clin Nephrol. 2013 Oct;80(4):256-62. doi: 10.5414/CN107905.

PMID:
23993165
15.

Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?

Haider DG, Masghati S, Goliasch G, Fuhrmann V, Soleiman A, Wolzt M, Baierl A, Druml W, Hörl WH.

J Nephrol. 2014 Dec;27(6):643-51. doi: 10.1007/s40620-014-0074-z. Epub 2014 Mar 8.

PMID:
24609889
16.

Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.

Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, Nitta K.

Nephrol Dial Transplant. 2010 Jan;25(1):278-82. doi: 10.1093/ndt/gfp485. Epub 2009 Sep 17.

PMID:
19762604
17.

Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function.

Lee JP, Heo NJ, Joo KW, Yi NJ, Suh KS, Moon KC, Kim SG, Kim YS.

Nephrol Dial Transplant. 2010 Aug;25(8):2772-85. doi: 10.1093/ndt/gfq093. Epub 2010 Mar 5.

PMID:
20207711
18.

Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction.

Ruebner R, Goldberg D, Abt PL, Bahirwani R, Levine M, Sawinski D, Bloom RD, Reese PP.

Am J Transplant. 2012 Nov;12(11):2958-65. doi: 10.1111/j.1600-6143.2012.04177.x. Epub 2012 Jul 3.

19.

Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus.

Thakar CV, Christianson A, Himmelfarb J, Leonard AC.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2567-72. doi: 10.2215/CJN.01120211. Epub 2011 Sep 8.

20.

Chronic kidney disease classification stratifies mortality risk after elective stent graft repair of the thoracic aorta.

Marrocco-Trischitta MM, Melissano G, Kahlberg A, Calori G, Setacci F, Chiesa R.

J Vasc Surg. 2009 Feb;49(2):296-301. doi: 10.1016/j.jvs.2008.09.041. Epub 2008 Nov 22.

Supplemental Content

Support Center